JustInTime (Talk | contribs) |
|||
(9 intermediate revisions by 3 users not shown) | |||
Line 91: | Line 91: | ||
</div> | </div> | ||
<div class="box3 left biosafety" href="https://2017.igem.org/Team:TAS_Taipei/Safety"> | <div class="box3 left biosafety" href="https://2017.igem.org/Team:TAS_Taipei/Safety"> | ||
− | <h1> | + | <h1>Safety</h1> |
</div> | </div> | ||
<div class="box3 left about" href="https://2017.igem.org/Team:TAS_Taipei/Team"> | <div class="box3 left about" href="https://2017.igem.org/Team:TAS_Taipei/Team"> | ||
Line 112: | Line 112: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="#SDS" class=" | + | <a href="#SDS" class="pageNavSm">SDS-PAGE Gel</a> |
</li> | </li> | ||
<li> | <li> | ||
− | <a href="#CR" class=" | + | <a href="#CR" class="pageNavSm">Congo Red Assay</a> |
</li> | </li> | ||
</ul> | </ul> | ||
Line 126: | Line 126: | ||
<header> | <header> | ||
<div class="row"> | <div class="row"> | ||
− | <h1 class="name col-lg-12">IMPROVE CHARACTERIZATION </h1> | + | <h1 class="name col-lg-12">IMPROVE CHARACTERIZATION OF EXISTING PART </h1> |
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
<h4 class="para col-lg-12"> | <h4 class="para col-lg-12"> | ||
− | <b>We improved the characterization of BBa_K342003 and BBa_K805015,</b> which contain the <i>ompR234</i> ORF and <i>csgD</i> ORF, respectively. We chose to characterize these parts because we wanted to use biofilm to capture nanoparticles. We looked through the distribution kit, found these two parts which regulate biofilm production, and tested them. We characterize the protein sizes of OmpR234 (BBa_K342003) and CsgD (BBa_K805015), and show that expression of OmpR234 and CsgD both increase biofilm production. | + | <b>We improved the characterization of <a href="http://parts.igem.org/Part:BBa_K342003">BBa_K342003</a> and <a href="http://parts.igem.org/Part:BBa_K805015">BBa_K805015</a>,</b> which contain the <i>ompR234</i> ORF and <i>csgD</i> ORF, respectively. We chose to characterize these parts because we wanted to use biofilm to capture nanoparticles. We looked through the distribution kit, found these two parts which regulate biofilm production, and tested them. We characterize the protein sizes of OmpR234 (BBa_K342003) and CsgD (BBa_K805015), and show that expression of OmpR234 and CsgD both increase biofilm production. |
</h4> | </h4> | ||
Line 165: | Line 165: | ||
<div class="row"> | <div class="row"> | ||
<h4 class="para col-lg-12"> | <h4 class="para col-lg-12"> | ||
− | + | ||
</h4> | </h4> | ||
</div> | </div> | ||
<div class="row" id="SDS"> | <div class="row" id="SDS"> | ||
− | <h1 class="col-lg-12 | + | <h1 class="col-lg-12 section-title">SDS-PAGE Gel</h1> |
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
Line 183: | Line 183: | ||
</div> | </div> | ||
<div class="row" id="CR"> | <div class="row" id="CR"> | ||
− | <h1 class="col-lg-12 | + | <h1 class="col-lg-12 section-title">Congo Red Assay</h1> |
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
<h4 class="para col-lg-12"> | <h4 class="para col-lg-12"> | ||
− | + | ||
</h4> | </h4> | ||
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
<h4 class="para col-lg-12"> | <h4 class="para col-lg-12"> | ||
− | To test if the overexpression of CsgD or OmpR234 actually lead to faster and | + | To test if the overexpression of CsgD or OmpR234 actually lead to faster and greater biofilm production, we used Congo Red (CR), a dye commonly used to measure biofilm production (Reinke & Gestwicki 2011). CR solution mixed with bacterial liquid cultures were grown in 12-well plates with glass coverslips, and incubated at 37˚C for one day. The samples were then washed with PBS and dried. Any stained biofilm on the glass coverslips was solubilized in ethanol, and absorbance was measured at 500 nm (figures 3-16 and 3-17). If biofilms were present, the solution would appear red, which could be quantified by an absorbance value. |
</h4> | </h4> | ||
</div> | </div> | ||
<div class="row"> | <div class="row"> | ||
<h4 class="para col-lg-12"> | <h4 class="para col-lg-12"> | ||
− | We find that <b>overexpressing either CsgD or OmpR234 increases biofilm production,</b> as we hypothesized (figure 3-16 and 3-17). In our experiments, overexpression of CsgD leads to about twice the amount of biofilm compared to BBa_K850015 (figure 3-16), whereas overexpression of OmpR234 leads to about 8 times more biofilm compared to BBa_K342003 (figure 3-17). When bacteria expressing OmpR234 was grown in petri dishes, biofilms appeared thicker compared to controls (figure 3-18). | + | We find that <b>overexpressing either CsgD or OmpR234 increases biofilm production,</b> as we hypothesized (figure 3-16 and 3-17). In our experiments, overexpression of CsgD leads to about twice the amount of biofilm compared to BBa_K850015 (figure 3-16), whereas overexpression of OmpR234 leads to about 8 times more biofilm compared to BBa_K342003 (figure 3-17). When bacteria expressing OmpR234 was grown in petri dishes, biofilms also appeared thicker compared to controls (figure 3-18). |
</h4> | </h4> | ||
</div> | </div> | ||
Line 212: | Line 212: | ||
<div class="row"> | <div class="row"> | ||
<div class="image_container col-lg-8 col-lg-offset-2"> | <div class="image_container col-lg-8 col-lg-offset-2"> | ||
− | <img src="https://static.igem.org/mediawiki/2017/7/ | + | <img src="https://static.igem.org/mediawiki/2017/7/79/T--TAS_Taipei--OMPR_Plate_Result.jpg" alt="test" id="group"> |
<h4 class="subtitle"><b> Figure 3-18 Overexpression of OmpR234 (BBa_K2229200) produces more biofilm compared to BBa_K342003, which contains just the ORF.</b><span class="subCred"> Experiment & Figure: Yvonne W.</span></h4> | <h4 class="subtitle"><b> Figure 3-18 Overexpression of OmpR234 (BBa_K2229200) produces more biofilm compared to BBa_K342003, which contains just the ORF.</b><span class="subCred"> Experiment & Figure: Yvonne W.</span></h4> | ||
</div> | </div> |
Latest revision as of 05:30, 1 November 2017
X
Project
Experiments
Modeling
Prototype
Human Practices
Safety
About Us
Attributions
Project
Experiment
Modeling
Prototype
Human Practice
Safety
About Us
Attributions
hi